InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-4.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Emster Kurt von. Officer active across 3 companies, notably Vera Therapeutics, Inc.. In total, 5 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €189k. History available since 17 May 2021. The latest transaction was disclosed on 29 September 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Emster Kurt von
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
90,000 sharesCommon StockSEC:0000950170-24-035435:0
15,921 shares@ US$5.00100.0% of flowCommon StockSEC:0001062993-23-018622:0
9,075 shares@ US$1.4903100.0% of flowVoting Common StockSEC:0001213900-23-029900:0
30,250 shares0Voting Common StockSEC:0001213900-22-063945:0
17,828 shares@ US$12.0404100.0% of flowClass A Common StockSEC:0001209191-21-033806:0
Canonical exit: 15 Aug 2021 (T+90)
5 of 5 declarations
About Emster Kurt von
EMSTER KURT VON is a Director of CymaBay Therapeutics, Inc., Jasper Therapeutics, Inc., and Vera Therapeutics, Inc. He has 6 filings in total, and across the 6 recent filings tracked, buys amount to EUR 353144 and sells to EUR 12234, between 2021-05-18 and 2024-03-22.
